| Literature DB >> 23915739 |
Farin Amersi1, Armando E Giuliano.
Abstract
The development and wide acceptance of sentinel lymph node biopsy (SLNB) has profoundly affected the management of breast cancer. SLNB has spared the additional morbidity of axillary lymph node dissection (ALND) without compromising diagnostic accuracy and prognostic information in patients with clinically node-negative early-stage breast cancer. It has become an invaluable tool to clinicians to guide decisions regarding adjuvant treatment. The management of breast cancer continues to advance to more minimally invasive approaches, and the role of ALND is likely to become less important in the future.Entities:
Keywords: ACOSOG Z0010; ACOSOG Z0011; Axillary node dissection; Sentinel lymph node biopsy
Mesh：
Year: 2013 PMID： 23915739 DOI： 10.1016/j.hoc.2013.05.002
Source DB: PubMed Journal: Hematol Oncol Clin North Am ISSN： 0889-8588 Impact factor: 3.722